Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical minoxidil nanosuspension versus 2% minoxidil solution for androgenetic alopecia
IRCT20180120038450N1Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of minoxidil in androgenetic alopecia (AGA) (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoints: Hair shaft diameter, Hair density and 10 more. Started Jun 2018; status: completed.
02
Drugs
minoxidil
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on IRCT20180120038450N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180120038450N1.